Pricing Log in Create free account
Friday 6 November 2026 Export BLLN’s income statement to Excel — free account

BillionToOne, Inc.

BLLN Healthcare Diagnostics & Research

BillionToOne, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $305.1 million, up 100.0% from fiscal 2024.

Revenue
+47.2%
EPS
+164.3%
Free cash flow
+9.25%
Total debt
+60.6%

Quarter to September 2026, against a year earlier

111.96 1.93 −1.69%
Market cap
$5.3B
P/E
88.7×
Fwd P/E
146×
Dividend yield
—
F-score
n/a
Altman Z
6.04
Beneish M
−2.03
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

BillionToOne, Inc. (BLLN) Gross margin

Alert me on Gross margin

BillionToOne, Inc.'s gross margin over the twelve months to 30 September 2026 was 71.4%, up 3.1 percentage points from fiscal 2025 (68.3%). That is above the Diagnostics & Research industry median of 48.3% and above the Healthcare sector median of 53.9%.

Gross margin, annual

Embed this chart

Annual newest first

Period Gross margin Change (points)
FY2025 68.3% 15.29
FY2024 53.0% 28.90
FY2023 24.1% —

Quarterly newest first

Period Gross margin Change (points)
Sep 2026 70.9% 0.41
Jun 2026 70.5% (2.52)
Mar 2026 73.0% 1.55
Dec 2025 71.4% 1.48
4 more quarters

Gross margin against peers

Company Gross margin
ADPT Adaptive Biotechnologies Corporation compare 74.2%
VCYT Veracyte, Inc. compare 72.0%
BLLN BillionToOne, Inc. 71.4%
CDNA CareDx, Inc. compare 71.0%
QGEN QIAGEN N.V. compare 62.2%
SHC Sotera Health Company compare 54.6%
NEO NeoGenomics, Inc. compare 44.8%
RDNT RadNet, Inc. compare 11.5%
GRAL GRAIL, Inc. compare 0.00%
Diagnostics & Research industry median 48.3%
Healthcare sector median 53.9%
Market median 45.1%

What Gross margin is

Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.

Gross Profit ÷ Revenue

The full definition of Gross margin →

More on BLLN